PGP and cancer: In general, these results claimed that BI-2865 might block the substrate drugs’ efflux by competing with drugs for the drug-binding sites of P-gp, leading to the increased ATP hydrolysis by P-gp ATPase, thus chemo drugs detained in cancer cells was increased.